Results 211 to 220 of about 4,184,278 (354)

EGaIn‐Activated Bioinspired Silk Micro/Nanofibril Eutectogels Breaking the Strength–Conductivity Trade‐Off for High‐Performance Wearable Bioelectronics

Advanced Science, EarlyView.
Inspired by the extracellular matrix, eutectogels are prepared by in situ deconstruction of silk fibroin into micro/nanofibrils and EGaIn‐induced polymerization. The multiscale fibril network with dynamic crosslinking achieves high strength (1.25 MPa), toughness (23.09 MJ m−3), and conductivity (1.51 S m−1), outperforming previous natural polymer ...
Haiwei Yang, Dongdong Ye, Yezi You, Ming Fu, Zongqian Wang   +4 more
wiley   +1 more source

Blood Component Utilization and Discard Patterns in Telangana, India: A Three-Year Retrospective Study. [PDF]

Cureus
Rai J, Behera NK, Gupta MK, Vemuri P, Kendre BD, Dixit H, Tiwari RV, Agrawal D, Gupta S.   +8 more
europepmc   +1 more source

Non‐Volatile Phase Modulation with Ultralow Energy Consumption Enabled by 2D Ferroelectric/TMD Heterostructures

Advanced Science, EarlyView.
We demonstrate a hybrid WS2/CuInP2S6/graphene heterostructure integrated on a silicon nitride microring resonator for non‐volatile optical phase modulation with ultra‐low energy consumption and low insertion loss. While CIPS alone does not provide efficient optical index modulation, the engineered proposed device structure converts ferroelctric domain ...
Lalit Singh, Shi Guo, Yuhui Yang, Sholehin Juperi, Rui Yu, Xiangxin Gong, Jeremy Leong, Sung‐Gyu Lee, Qingyun Wu, Lay Kee Ang, Sang Hoon Chae   +10 more
wiley   +1 more source

Nucleic acid testing in Colombian blood banks (2018-2024): Implementation, yield estimates and implications for safer transfusion policy. [PDF]

Vox Sang
Bermúdez-Forero MI, García-Otálora MA.   +1 more
europepmc   +1 more source

Targeted Degradation of eEF2K by a Structure‐Guided PROTAC Strategy for the Treatment of Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
This study developed an eEF2K‐targeting PROTAC, A6, that efficiently degrades eEF2K in TNBC cells, inhibiting tumor growth in vitro and in vivo. To enhance tumor‐specific delivery, we engineered A6@ZIF‐8, a pH‐sensitive nanocarrier, which improved drug accumulation at tumor sites, offering a promising therapeutic strategy for TNBC through targeted ...
Shijun Cao, Changxin Zhong, Shilong Jiang, Yungui Li, Yang Xi, Mingxuan Xiao, Ting Jiang, Xiaoya Wan, Zonglin Chen, Xiaohui Yu, Yan Cheng   +10 more
wiley   +1 more source

Evaluation of the TrueBeam machine-performance-check (MPC): Collimator device check (CDC). [PDF]

J Appl Clin Med Phys
Barnes M, Dipuglia A, Beeksma B, Lehmann J.   +3 more
europepmc   +1 more source

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Advanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi   +5 more
wiley   +1 more source

A Clinical Workflow for Evaluating Dose to Organs at Risk After Biology-Guided Radiation Therapy Delivery. [PDF]

Cancers (Basel)
Banks TI, Shen C, Godley AR, Park YK, Prasad R, Ravikiran M, Badiyan SN, Dan T, Garant A, Timmerman R, Jiang S, Cai B.   +11 more
europepmc   +1 more source

A Universal Metal–Flavonoid Coating Strategy: Engineering Biomaterials for Diabetic Bone Regeneration

Advanced Science, EarlyView.
Construction of metal–flavonoid functionalized coatings on conventional bone repair materials. A one‐pot method is used to directly construct multifunctional metal–flavonoid coatings on the surface of traditional bone repair materials by selecting metal ions with osteogenic/angiogenic properties and flavonoids with reactive oxygen species scavenging ...
Chen Yang, Chenle Dong, Lefeng Su, Zhiqiang Liu, Lingyi Hu, Qishu Jin, Hao Chen, Chunlong Zhang, Yihao Wu, Jiang Chang, Zhaowenbin Zhang, Jiandong Yuan   +11 more
wiley   +1 more source

Editorial-A Milestone in the Technological Development of Hadrontherapy, in FranceHadrontherapy, cryogenic cyclotron. [PDF]

Int J Part Ther
Habrand JL, Gaubert G, Haghdoost S, Thariat J, Rouzier R.   +4 more
europepmc   +1 more source